Markus Hecht

32PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyInstruments and techniquesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.

Rainer Fietkau, Michael Ghadimi, Robert Grützmann

|Jan 31, 2025
Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy.

Jian-Guo Zhou, Jie Yang, Haitao Wang

|Jul 27, 2024
Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation.

Benjamin M Freyter, Mutaz A Abd Al-Razaq, Markus Hecht

|Jan 11, 2024
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy.

Shixiang Wang, Yi Xiong, Yihao Zhang

|Oct 27, 2023
Automated Image Analysis of Transmission Electron Micrographs: Nanoscale Evaluation of Radiation-Induced DNA Damage in the Context of Chromatin.

Mutaz A Abd Al-Razaq, Anna Isermann, Markus Hecht

|Jan 05, 2023
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.

Thomas Weissmann, Michael Rückert, Florian Putz

Pageof 6

Frequent Collaborators

13 joint publications

Benjamin Frey

12 joint publications

Luitpold V Distel

12 joint publications

Udo S Gaipl

6 joint publications

Sandra Rutzner